000 | 01508 a2200385 4500 | ||
---|---|---|---|
005 | 20250518083458.0 | ||
264 | 0 | _c20201029 | |
008 | 202010s 0 0 eng d | ||
022 | _a2299-5684 | ||
024 | 7 |
_a10.1007/s43440-019-00038-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRomán, Marie | |
245 | 0 | 0 |
_aSignificant reduction of vascular reactivity with dantrolene and nimodipine in diabetic rats: a potential approach to cerebral vasospasm management in diabetes. _h[electronic resource] |
260 |
_bPharmacological reports : PR _cFeb 2020 |
||
300 |
_a126-134 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 |
_aAcetylcholine _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aDantrolene _xadministration & dosage |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xcomplications |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNimodipine _xadministration & dosage |
650 | 0 | 4 |
_aPhenylephrine _xadministration & dosage |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aVasodilator Agents _xadministration & dosage |
650 | 0 | 4 |
_aVasospasm, Intracranial _xetiology |
700 | 1 | _aRamírez, José M | |
700 | 1 | _aMorales, Myrna | |
700 | 1 | _aCrespo, María J | |
773 | 0 |
_tPharmacological reports : PR _gvol. 72 _gno. 1 _gp. 126-134 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s43440-019-00038-5 _zAvailable from publisher's website |
999 |
_c30594626 _d30594626 |